Humana Inc (NYSE:HUM) gapped up prior to trading on Thursday . The stock had previously closed at $255.08, but opened at $267.91. Humana shares last traded at $280.19, with a volume of 2,338,947 shares.

Several research firms have issued reports on HUM. Zacks Investment Research lowered shares of Hollysys Automation Technologies from a “hold” rating to a “sell” rating in a report on Thursday, April 11th. Morgan Stanley lifted their price target on shares of Zynga and gave the stock an “overweight” rating in a report on Thursday, May 2nd. Oppenheimer cut their price target on shares of Littelfuse from $215.00 to $210.00 and set an “outperform” rating on the stock in a report on Thursday, May 2nd. UBS Group set a $36.00 price target on shares of Halliburton and gave the stock a “buy” rating in a report on Tuesday, April 23rd. Finally, Citigroup lowered shares of BCE from a “buy” rating to a “neutral” rating in a report on Thursday, May 2nd. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have assigned a buy rating to the company. Humana presently has an average rating of “Buy” and an average price target of $337.26.

The company has a market capitalization of $35.74 billion, a PE ratio of 19.26, a PEG ratio of 1.09 and a beta of 0.87. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.40. The company’s fifty day simple moving average is $258.06.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, May 1st. The insurance provider reported $4.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.30 by $0.18. The company had revenue of $16.11 billion during the quarter, compared to the consensus estimate of $15.67 billion. Humana had a net margin of 2.99% and a return on equity of 20.77%. The firm’s quarterly revenue was up 12.8% on a year-over-year basis. During the same period in the previous year, the firm posted $3.36 earnings per share. Sell-side analysts anticipate that Humana Inc will post 17.48 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $2.20 dividend on an annualized basis and a yield of 0.79%. Humana’s dividend payout ratio is presently 15.12%.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Tributary Capital Management LLC raised its position in shares of Humana by 17.6% in the second quarter. Tributary Capital Management LLC now owns 2,000 shares of the insurance provider’s stock worth $531,000 after acquiring an additional 300 shares during the period. AMF Pensionsforsakring AB raised its position in shares of Humana by 5.7% in the second quarter. AMF Pensionsforsakring AB now owns 118,256 shares of the insurance provider’s stock worth $31,373,000 after acquiring an additional 6,412 shares during the period. First National Bank of Omaha raised its position in shares of Humana by 17.8% in the second quarter. First National Bank of Omaha now owns 20,529 shares of the insurance provider’s stock worth $5,446,000 after acquiring an additional 3,099 shares during the period. Scout Investments Inc. raised its position in shares of Humana by 440.3% in the second quarter. Scout Investments Inc. now owns 79,217 shares of the insurance provider’s stock worth $21,016,000 after acquiring an additional 64,555 shares during the period. Finally, Crossmark Global Holdings Inc. raised its position in shares of Humana by 5.7% in the second quarter. Crossmark Global Holdings Inc. now owns 15,341 shares of the insurance provider’s stock worth $4,070,000 after acquiring an additional 823 shares during the period. Institutional investors own 92.61% of the company’s stock.

About Humana (NYSE:HUM)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: What is channel trading?

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.